Journal of Nuclear Medicine Vol. 46 No. 10 8a-9a
© 2005 by Society of Nuclear Medicine
THIS MONTH IN JNM
Schillaci reviews the benefits and current clinical applications of scintimammography and assesses the technological developments that would allow this modality to become a routine adjunct in breast cancer imaging.
Page 1571
Mathieu and colleagues report on the results of a retrospective study exploring the effect of scintimammography as a complementary tool in the management of patients with inconclusive triple diagnoses (mammography, ultrasound, and fine-needle aspiration cytology) suggesting breast cancer.
Page 1574
Yun and colleagues compare 18F-FDG PET with CT in the evaluation of primary tumors and lymph node metastases in early and advanced gastric cancer and discuss the implications of these findings for the identification of optimal initial therapies.
Page 1582
Elhendy and colleagues investigate whether the presence of ischemia on stress myocardial perfusion imaging is a significant predictor of deaths from all causes during long-term follow-up in patients with diabetes mellitus.
Page 1589
Emmett and colleagues report on clinical factors that may influence the incidence of transient ischemic dilation on myocardial perfusion SPECT, with specific attention to the effects of left ventricular hypertrophy and diabetes.
Page 1596
Stankewicz and colleagues compare the effectiveness of 82Rb washout studies with PET 18F-FDG–82Rb mismatch studies in the accurate assessment of myocar-dial viability in patients with coronary artery disease.
Page 1602
Yaoita and colleagues use myocardial perfusion scintigraphy to evaluate the regenerative effects of autologous bone marrow–derived mononuclear cell transplantation into ischemic myocardium in patients who undergo off-pump coronary artery bypass surgery.
Page 1610
Freedman and colleagues assess the ability of 11C-L-deprenyl PET to demonstrate the specific binding characteristics of the novel irreversible selective monoamine oxidase B inhibitor rasagiline, which may have beneficial applications in the treatment of early-stage Parkinson’s disease.
Page 1618
Drzezga and colleagues report on a longitudinal study designed to determine the combined value of genotyping and 18F-FDG PET assessment of cerebral glucose metabolism in the early diagnosis of Alzheimer’s type dementia in patients with mild cognitive impairment.
Page 1625
Chen and colleagues describe and validate a rapid 18F-FDG PET brain imaging protocol and compare it with conventional protocols in assessing glucose metabolism in patients with and without Alzheimer’s disease.
Page 1633
Farsad and colleagues evaluate the potential usefulness of 11C-choline PET/CT for detection and localization of tumors within the prostate and compare these imaging findings with histopathologic results.
Page 1642
Installé and colleagues assess the ability of 18F-fluoride PET to monitor therapeutic response to bisphosphonates in patients with Paget’s disease and discuss the implications for routine use of whole-body PET for this purpose.
Page 1650
Wong and colleagues report on a study designed to derive an optimal glucose sensitivity factor and most discriminating standardized uptake value normalized to glucose for the use of 18F-FDG PET in classifying indolent and aggressive lymphomas.
Page 1659
Schwaiger and colleagues review current challenges and potential for PET/CT in the routine characterization of coronary artery disease and speculate on future clinical applications in cardiology.
Page 1664
Jönsson and colleagues simulate scintillation camera images of patients and evaluate the accuracy of 2 methods designed to minimize the confounding effects of scattered radiation from adjacent organs and activity from overlapping tissues.
Page 1679
Lee and colleagues describe a noninvasive, fast, and accurate method for estimating myocardial blood flow and generating a parametric image using a novel linear least-squares estimation technique and H215O dynamic myocardial PET.
Page 1687
de Jong and colleagues use 111In-DTPA-octreotide SPECT in mice to investigate the role of megalin in renal tubular reabsorption of radiolabeled somatostatin ana-logs, with implications for tumor diagnosis and radionuclide therapy.
Page 1696
Chéhadé and colleagues apply secondary ion mass spectrometry to obtain quantitative and qualitative data on the biodistribution of a 14C-labeled melanoma-targeting molecule in mice and discuss the potential for this technique in molecular analysis of radiopharmaceutical action and distribution.
Page 1701
Wu and colleagues investigate a novel 64Cu-labeled tetrameric RGD peptide tracer with promise for PET imaging of integrin 
vß3 expression in solid tumors and as a therapeutic radiopharmaceutical in integrin-positive tumors.
Page 1707
Mathews and colleagues synthesize and evaluate in a mouse model a positron-emitting analog of a nuclear receptor that plays a central role in the control of lipid and glucose metabolism.
Page 1719
Nock and colleagues evaluate 3 new modified 99mTc-labeled minigastrin analogs in both in vitro and animal models for their suitability in cholecystokinin subtype 2/gastrin receptor–targeted imaging of tumors.
Page 1727
Pan and colleagues investigate a method for improving the consistency of analysis in 18F-FDOPA PET images obtained to assess the diminished functionality of the striatum in patients with suspected Parkinson’s disease.
Page 1737
Chan and colleagues describe the synthesis of a novel radiolabeled recombinant vascular endothelial growth factor receptor–binding protein for imaging tumor angiogenesis.
Page 1745
Lee and colleagues study differential glucose uptake and transport patterns in hepatocellular carcinomas and cholangiocarcinomas and discuss the potential roles of tumor-suppressor genes in these differences as well as implications for 18F-FDG PET imaging of oncogenic variations.
Page 1753
| ON THE COVER
At top, nodular HCC in the inferior segment of the right lobe of the liver shows increased 18F-FDG uptake on PET. Immunohistochemical staining shows a negative reaction for Glut 1 but a positive reaction for hexokinase type II (HK II). At bottom, a mass-forming cholangiocarcinoma in the inferior segment of the right lobe of the liver shows intense 18F-FDG uptake. Pathologically, the tumor shows a strong positive reaction for Glut 1 along the cell membrane but a negative reaction for HK II.
|
Related articles in JNM:
- Is There a Clinical Role for Scintimammography in Breast Cancer Diagnosis?
- Orazio Schillaci
JNM 2005 46: 1571-1573.
[Full Text]
- Inconclusive Triple Diagnosis in Breast Cancer Imaging: Is There a Place for Scintimammography?
- Isabelle Mathieu, Stéphane Mazy, Bernard Willemart, Michel Destine, Gilbert Mazy, and Max Lonneux
JNM 2005 46: 1574-1581.
[Abstract]
[Full Text]
- Lymph Node Staging of Gastric Cancer Using 18F-FDG PET: A Comparison Study with CT
- Mijin Yun, Joon Seok Lim, Sung Hoon Noh, Woo Jin Hyung, Jae Ho Cheong, Jung Kyun Bong, Arthur Cho, and Jong Doo Lee
JNM 2005 46: 1582-1588.
[Abstract]
[Full Text]
- Association of Ischemia on Stress99mTc-Tetrofosmin Myocardial Perfusion Imaging with All-Cause Mortality in Patients with Diabetes Mellitus
- Abdou Elhendy, Aukje Huurman, Arend F.L. Schinkel, Jeroen J. Bax, Ron T. van Domburg, Roelf Valkema, Elena Biagini, and Don Poldermans
JNM 2005 46: 1589-1595.
[Abstract]
[Full Text]
- The Role of Left Ventricular Hypertrophy and Diabetes in the Presence of Transient Ischemic Dilation of the Left Ventricle on Myocardial Perfusion SPECT Images
- Louise Emmett, Michael Magee, S. Ben Freedman, Hans Van der Wall, Vivienne Bush, Joseph Trieu, William Van Gaal, Kevin C. Allman, and Leonard Kritharides
JNM 2005 46: 1596-1601.
[Abstract]
[Full Text]
- Myocardial Viability Assessment by PET: 82Rb Defect Washout Does Not Predict the Results of Metabolic–Perfusion Mismatch
- Mark A. Stankewicz, Craig S. Mansour, Robert L. Eisner, Keith B. Churchwell, Byron R. Williams, Steven R. Sigman, James Streeter, and Randolph E. Patterson
JNM 2005 46: 1602-1609.
[Abstract]
[Full Text]
- Scintigraphic Assessment of the Effects of Bone Marrow–Derived Mononuclear Cell Transplantation Combined with Off-Pump Coronary Artery Bypass Surgery in Patients with Ischemic Heart Disease
- Hiroyuki Yaoita, Shinya Takase, Yukio Maruyama, Yoshiyuki Sato, Hirono Satokawa, Nobuo Hoshi, Nobutaka Ono, Tsuguo Igari, Hitoshi Ohto, and Hitoshi Yokoyama
JNM 2005 46: 1610-1617.
[Abstract]
[Full Text]
- In Vivo Measurement of Brain Monoamine Oxidase B Occupancy by Rasagiline, Using 11C-L-Deprenyl and PET
- Nanette M.T. Freedman, Eyal Mishani, Yodphat Krausz, Jolie Weininger, Hava Lester, Eran Blaugrund, Daphna Ehrlich, and Roland Chisin
JNM 2005 46: 1618-1624.
[Abstract]
[Full Text]
- Prediction of Individual Clinical Outcome in MCI by Means of Genetic Assessment and 18F-FDG PET
- Alexander Drzezga, Timo Grimmer, Matthias Riemenschneider, Nicola Lautenschlager, Hartwig Siebner, Panagiotis Alexopoulus, Satoshi Minoshima, Markus Schwaiger, and Alexander Kurz
JNM 2005 46: 1625-1632.
[Abstract]
[Full Text]
- Rapid Scanning Protocol for Brain 18F-FDG PET: A Validation Study
- Wei Ping Chen, Ichiro Matsunari, Akihiro Noda, Daisuke Yanase, Kazuyoshi Yajima, Nozomi Takeda, Masahito Yamada, Satoshi Minoshima, and Shintaro Nishimura
JNM 2005 46: 1633-1641.
[Abstract]
[Full Text]
- Detection and Localization of Prostate Cancer: Correlation of 11C-Choline PET/CT with Histopathologic Step-Section Analysis
- Mohsen Farsad, Riccardo Schiavina, Paolo Castellucci, Cristina Nanni, Barbara Corti, Giuseppe Martorana, Romeo Canini, Walter Grigioni, Stefano Boschi, Mario Marengo, Cinzia Pettinato, Eugenio Salizzoni, Nino Monetti, Roberto Franchi, and Stefano Fanti
JNM 2005 46: 1642-1649.
[Abstract]
[Full Text]
- 18F-Fluoride PET for Monitoring Therapeutic Response in Paget’s Disease of Bone
- Johanne Installé, Adrien Nzeusseu, Anne Bol, Geneviève Depresseux, Jean-Pierre Devogelaer, and Max Lonneux
JNM 2005 46: 1650-1658.
[Abstract]
[Full Text]
- Glucose-Normalized Standardized Uptake Value from 18F-FDG PET in Classifying Lymphomas
- Ching-yee Oliver Wong, Joseph Thie, Kelly J. Parling-Lynch, Dana Zakalik, Jeffrey H. Margolis, Marianne Gaskill, Jack Hill, Feng Qing, Darlene Fink-Bennett, and Conrad Nagle
JNM 2005 46: 1659-1663.
[Abstract]
[Full Text]
- PET/CT: Challenge for Nuclear Cardiology
- Markus Schwaiger, Sibylle Ziegler, and Stephan G. Nekolla
JNM 2005 46: 1664-1678.
[Abstract]
[Full Text]
- Evaluation of Accuracy in Activity Calculations for the Conjugate View Method from Monte Carlo Simulated Scintillation Camera Images Using Experimental Data in an Anthropomorphic Phantom
- Lena Jönsson, Michael Ljungberg, and Sven-Erik Strand
JNM 2005 46: 1679-1686.
[Abstract]
[Full Text]
- Generation of Parametric Image of Regional Myocardial Blood Flow Using H215O Dynamic PET and a Linear Least-Squares Method
- Jae Sung Lee, Dong Soo Lee, Ji Young Ahn, Jeong Seok Yeo, Gi Jeong Cheon, Seok-Ki Kim, Kwang Suk Park, June-Key Chung, and Myung Chul Lee
JNM 2005 46: 1687-1695.
[Abstract]
[Full Text]
- Megalin Is Essential for Renal Proximal Tubule Reabsorption of 111In-DTPA-Octreotide
- Marion de Jong, Raffaella Barone, Eric Krenning, Bert Bernard, Marleen Melis, Theo Visser, Michael Gekle, Thomas E. Willnow, Stephan Walrand, François Jamar, and Stanislas Pauwels
JNM 2005 46: 1696-1700.
[Abstract]
[Full Text]
- Secondary Ion Mass Spectrometry as a Tool for Investigating Radiopharmaceutical Distribution at the Cellular Level: The Example of I-BZA and 14C-I-BZA
- Féras Chéhadé, Claire de Labriolle-Vaylet, Nicole Moins, Marie-France Moreau, Janine Papon, Pierre Labarre, Pierre Galle, Annie Veyre, and Elif Hindié
JNM 2005 46: 1701-1706.
[Abstract]
[Full Text]
- microPET Imaging of Glioma Integrin vß3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide
- Yun Wu, Xianzhong Zhang, Zhengming Xiong, Zhen Cheng, Darrell R. Fisher, Shuang Liu, Sanjiv S. Gambhir, and Xiaoyuan Chen
JNM 2005 46: 1707-1718.
[Abstract]
[Full Text]
- Synthesis and Biodistribution of 11C-GW7845, a Positron-Emitting Agonist for Peroxisome Proliferator–Activated Receptor-
- William B. Mathews, Catherine A. Foss, Doris Stoermer, Hayden T. Ravert, Robert F. Dannals, Brad R. Henke, and Martin G. Pomper
JNM 2005 46: 1719-1726.
[Abstract]
[Full Text]
- CCK-2/Gastrin Receptor–Targeted Tumor Imaging with 99mTc-Labeled Minigastrin Analogs
- Berthold A. Nock, Theodosia Maina, Martin Béhé, Anastasia Nikolopoulou, Martin Gotthardt, Jörg S. Schmitt, Thomas M. Behr, and Helmut R. Mäcke
JNM 2005 46: 1727-1736.
[Abstract]
[Full Text]
- Improving Influx Constant and Ratio Estimation in FDOPA Brain PET Analysis for Parkinson’s Disease
- Xiao-Bo Pan, Thomas G. Wright, F. Joel Leong, Robert A. McLaughlin, Jérôme M. Declerck, and Daniel H.S. Silverman
JNM 2005 46: 1737-1744.
[Abstract]
[Full Text]
- A Human Transferrin-Vascular Endothelial Growth Factor (hnTf-VEGF) Fusion Protein Containing an Integrated Binding Site for 111In for Imaging Tumor Angiogenesis
- Conrad Chan, Jasbir Sandhu, Abhijit Guha, Deborah A. Scollard, Judy Wang, Paul Chen, Karen Bai, Lydia Lee, and Raymond M. Reilly
JNM 2005 46: 1745-1752.
[Abstract]
[Full Text]
- Different Glucose Uptake and Glycolytic Mechanisms Between Hepatocellular Carcinoma and Intrahepatic Mass-Forming Cholangiocarcinoma with Increased 18F-FDG Uptake
- Jong Doo Lee, Woo Ick Yang, Young Nyun Park, Kyung Sik Kim, Jin Sub Choi, Mijin Yun, Dooheun Ko, Tae-Sung Kim, Arthur E.H. Cho, Hye Mi Kim, Kwang-Hyub Han, Seung-Soon Im, Yong-Ho Ahn, Chang Woon Choi, and Jeon Han Park
JNM 2005 46: 1753-1759.
[Abstract]
[Full Text]
